Cancer membrane-associated proteins have been targeted to develop cancer therapeutics, such as herceptin (her2neu) [17], Panorex (Ep-CAM) [18] and IRESSA (epidermal growth factor receptor) [19]. Here, EPCAM is linked to cancer.